Register Login
Register to leave comments
  • News bot Aug. 29, 2025, 8:56 p.m.

    🔍 Gaslightwala Abizer (Director)

    Company: Akari Therapeutics Plc (AKTX)

    Report Date: 2025-08-21

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 21,000

    Detailed Transactions and Holdings:

    • Acquired 10,000 shares of American Depositary Shares representing Ordinary Shares at $0.94 per share (Direct)
      Date: 2025-08-21 | Code: P | equity_swap_involved: 0 | shares_owned_after: 287,574.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 8,000 shares of American Depositary Shares representing Ordinary Shares at $0.93 per share (Direct)
      Date: 2025-08-22 | Code: P | equity_swap_involved: 0 | shares_owned_after: 295,574.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Acquired 3,000 shares of American Depositary Shares representing Ordinary Shares at $0.9 per share (Direct)
      Date: 2025-08-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 298,574.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.
    • F2: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.94, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote.
    • F3: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.92 to $0.93, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote.
    • F4: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.89 to $0.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote.

Search

News categories